Tafenoquine: WHO awards prequalification to single-dose medicine for P. vivax malaria Ruchika Sharma5 Dec 2024 12:30 PM ISTLondon: GSK plc and Medicines for Malaria Venture (MMV) has announced that the World Health Organization (WHO) has awarded prequalification to...
GSK fully liquid Menveo meningococcal vaccine approved by European Commission Ruchika Sharma29 Nov 2024 12:39 PM ISTLondon: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of...
USFDA accepts for review application for GSK Blenrep combinations for multiple myeloma treatment Ruchika Sharma26 Nov 2024 5:52 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
GSK, Vesalius Therapeutics collaborate for novel treatments for Parkinson's disease Ruchika Sharma16 Nov 2024 12:35 PM ISTCambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, has...
GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia Ruchika Sharma14 Nov 2024 1:15 PM ISTMississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or...
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk Ruchika Sharma11 Nov 2024 1:00 PM ISTMississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada for the prevention of...
Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine Ruchika Sharma9 Oct 2024 2:33 PM ISTLondon: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...
GSK announces positive results from phase III trial of Nucala in COPD Ruchika Sharma8 Sept 2024 1:30 PM ISTLondon: GSK plc has announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) a...
GSK Nucala approved in Japan for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2024 4:19 PM ISTGSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Nucala (mepolizumab), a monoclonal antibody that...
Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B: GSK Ruchika Sharma3 Sept 2024 9:30 AM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted SENKU (formerly known as SAKIGAKE)...
GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer Ruchika Sharma21 Aug 2024 11:30 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...
US FDA expands Jemperli plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma2 Aug 2024 10:00 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and...
